Radiation Therapy Second Degree Option
The Radiation Therapy Program is open to all applicants who have completed a bachelor's degree, the programmatic prerequisites and other program requirements.
Application and Admission Process
Applicants must submit an application, transcripts and letters of recommendation. Selected candidates must attend an interview with the program’s admissions committee. Learn more on our Application Procedure page.
We can provide fast feedback about your transcript(s) and pre-requisite coursework. Simply complete the form below by attaching unofficial copies of your transcript(s).
The 2nd Degree Option for Bachelor of Health Science program requires a minimum of 62 credit hours for completion, which usually takes five semesters of full-time study after the programmatic prerequisites are completed. Students are admitted into the program prior to the start of the fall semester. Students must be enrolled full time and complete each semester successfully in order to proceed to the next semester.
Students are typically in the classroom two days per week and in a clinical environment three days per week. Students will be involved with class or clinic approximately 40 hours per week. Both classroom and laboratory sessions will utilize the VERT (Virtual Environment Radiotherapy Trainer).
Any undergraduate degree from a regionally accredited institution. Human Anatomy and Physiology I and II, Chemistry for the Health Sciences, College Physics I and II (algebra or trigonometry based), Precalculus, and Medical Terminology. All programmatic pre-requisites must have a grade of “C-” or better and an overall program prerequisite GPA of 2.5 or higher.
Prerequisite and co-requisite courses do not expire; however, students must be familiar with the material contained in these courses to be successful in the program.
The Radiation Therapy Program seeks technologically adept individuals who have excellent interpersonal skills. The successful applicant will be highly motivated and dedicated to working with cancer patients.